We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




DNA-Based Analysis Detects Group A Streptococcus

By LabMedica International staff writers
Posted on 27 Oct 2016
As an exclusively human pathogen, Group A Streptococcus (GAS; Streptococcus pyogenes) is spread in the community through direct human-to-human transmission and GAS can also colonize a healthy host without any apparent clinical signs or symptoms.

In clinical microbiology, standard cultivation methods are considered the ‘gold standard’ for microorganism detection because the phenotypic characterization of clinical isolates is important for determining the treatment directions, but such methods are laborious and time-consuming.

Medical microbiologist at the Tokyo Medical and Dental University (Japan) and their colleagues collected throat swab samples from October 2013 to June 2014 from students and staff from various departments of the university. More...
Two throat swabs were collected from the upper pharyngeal region of each of the 148 volunteers. One swab was dipped into 500 μL of sterile Trypticase soy broth for the culture-dependent study. The other swab was dipped into 600 μL of the sterile bead solution from the PowerSoil DNA isolation kit (MO BIO Laboratories, Carlsbad, CA, USA) and stored.

Two methods, culture dependent and independent, were used to detect GAS in throat swabs from healthy adults. For the culture-dependent method, swabs were streaked onto two types of agar medium and in addition to streaking; each throat swab dipped tryptic soy broth (TSB) and was also added to 1.2 mL of fresh TSB for enrichment. For the culture-independent study DNA extracted from the other was amplified by polymerase chain reaction (PCR) with two GAS-specific primer pairs: one was a newly designed 16S rRNA-specific primer pair, the other a previously described V-Na+-ATPase primer pair. The cloned PCR products were sequenced using M13 primers and the 3130 Genetic Analyzer (Applied Biosystems, Foster City CA, USA).

The scientists found that although only five (3.4%) of the 148 samples were GAS-positive by the culture-dependent method, 146 (98.6%) were positive for the presence of GAS DNA by the culture-independent method. To obtain serotype information by M type protein gene (emm) typing, they performed nested PCR using newly designed emm primers. They detected the four different emm types in 25 (16.9%) samples, and these differed from the common emm types associated with GAS associated diseases in Japan. The different emm types detected in the healthy volunteers indicate that the presence of unique emm types might be associated with GAS carriage.

The authors concluded that culture-independent methods should be considered for profiling GAS in the healthy hosts, with a view to obtaining better understanding of these organisms. The GAS-specific primers (16S rRNA and V-Na+-ATPase) used in this study can be used to estimate the maximum potential GAS carriage in people. These results suggest that not only school-age children, but also healthy adults can serve as GAS carriers. The study was published on October 11, 2016, in the journal BMC Microbiology.

Related Links:
Tokyo Medical and Dental University
MO BIO Laboratories
Applied Biosystems

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Biochemistry Analyzer
Chemi+ 8100
New
UHF RFID Tag & Inlay
AD-327 U9 ETSI Pure 95
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Gut microbes may help in recognizing and treating pancreatic cancer (Photo courtesy of Adobe Stock)

Gut Microbes Could Enable Early Detection and Treatment of Pancreatic Cancer

Pancreatic cancer remains one of the most serious and challenging diseases in oncology due to its difficulty in detection and limited treatment options. Now, a new international collaborative study suggests... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Industry

view channel
Image: The knowledge transfer partnership will further develop technology to rapidly diagnose serious and high-risk infectious diseases (Photo courtesy of Aston University)

Aston University and BG Research Partner to Commercialize Groundbreaking Medical Diagnostic

Technology that can rapidly diagnose high-consequence infectious diseases will take a major step forward towards commercialization, thanks to a new partnership. A Knowledge Transfer Partnership (KTP)... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.